The Chosun Ilbo on MSN
Global pharma, Korean firms race in dementia drug development
U.S. pharmaceutical company Eli Lilly plans to disclose the topline results of its phase 3 clinical trial for remternemab, a new drug candidate developed as a successor to its Alzheimer’s treatment ...
New research shows that aging blood can accelerate Alzheimer’s-like changes in the brain, while younger blood may offer ...
Alzheimer's disease (AD) is a serious neurodegenerative disease largely affecting older adults. Apart from age, it also shows ...
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein ...
An international research team reveals new molecular mechanisms associated with pathogenic mutations in the protein transthyretin that cause ...
Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback